Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25288 | 21991518 | ISRN Gastroenterol | Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease. | 2011 | Details |
| A25291 | 21990946 | World J Gastroenterol | Betaine and nonalcoholic steatohepatitis: back to the future? | 2011 | Details |
| A25294 | 21987620 | World J Gastroenterol | JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease. | 2011 | Details |
| A25305 | 21983273 | Biochim Biophys Acta | Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice. | 2011 | Details |
| A25312 | 21967816 | Am J Pathol | Insulin resistance and metabolic hepatocarcinogenesis with parent-of-origin effects in A×B mice. | 2011 | Details |
| A25315 | 21963564 | Biochim Biophys Acta | Liver triacylglycerol lipases. | 2011 | Details |
| A25317 | 21962038 | BMC Public Health | Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. | 2011 | Details |
| A25320 | 21958082 | Clin Transplant | Implications of worse renal dysfunction and medical comorbidities in patients with NASH undergoing liver transplant evaluation: impact on MELD and more. | 2011 | Details |
| A25321 | 21957486 | PLoS One | GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy. | 2011 | Details |
| A25322 | 21957160 | Am J Physiol Regul Integr Comp Physiol | Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease. | 2011 | Details |
| A25323 | 21956711 | Diabetologia | Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial. | 2011 | Details |
| A25325 | 21954411 | World J Hepatol | Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis. | 2011 | Details |
| A25328 | 21953137 | Dig Dis Sci | Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. | 2011 | Details |
| A25330 | 21952989 | Hepatology | "Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country. | 2011 | Details |
| A25337 | 21948570 | Turk J Gastroenterol | A new risk factor for the development of non-alcoholic fatty liver disease: HLA complex genes. | 2011 | Details |
| A25339 | 21948267 | Obes Surg | Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgery. | 2011 | Details |
| A25341 | 21947639 | Nutr Clin Pract | Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy. | 2011 | Details |
| A25345 | 21943357 | Nutr Metab (Lond) | The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and non alcoholic fatty liver disease (NAFLD) in rats. | 2011 | Details |
| A25347 | 21940337 | Hepatogastroenterology | Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in NAFLD. | 2011 | Details |
| A25351 | 21936721 | Scand J Gastroenterol | Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice. | 2011 | Details |
| A25352 | 21935484 | PLoS One | The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. | 2011 | Details |
| A25355 | 21932408 | Hepatology | Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. | 2011 | Details |
| A25356 | 21932374 | Liver Transpl | Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. | 2012 | Details |
| A25361 | 21926952 | Minerva Ginecol | [Polycystic ovarian syndrome incidence in young women with non-alcoholic fatty liver disease]. | 2011 | Details |
| A25363 | 21918648 | Curr Gerontol Geriatr Res | Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly. | 2011 | Details |
| A25364 | 21917086 | Hepatol Res | Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic? | 2011 | Details |
| A25365 | 21905818 | Int J Pediatr Obes | Fatty liver disease in obese children--relation to other metabolic risk factors. | 2011 | Details |
| A25366 | 21915061 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase. | 2011 | Details |
| A25369 | 21912450 | World J Gastroenterol | Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. | 2011 | Details |
| A25370 | 21912108 | Ann Nutr Metab | Early-onset metabolic syndrome in prepubertal obese children and the possible role of alanine aminotransferase as marker of metabolic syndrome. | 2011 | Details |
| A25372 | 21911891 | Ann Hepatol | Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25373 | 21911890 | Ann Hepatol | Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet. | 2011 | Details |
| A25374 | 21910085 | Adv Exp Med Biol | Glycosphingolipids and insulin resistance. | 2011 | Details |
| A25375 | 21910084 | Adv Exp Med Biol | Sphingolipids and hepatic steatosis. | 2011 | Details |
| A25376 | 21910083 | Adv Exp Med Biol | Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity. | 2011 | Details |
| A25378 | 21907687 | J Hepatol | Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis. | 2011 | Details |
| A25379 | 21907177 | Am J Pathol | Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet. | 2011 | Details |
| A25380 | 21906580 | Am J Pathol | Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis. | 2011 | Details |
| A25384 | 21903748 | J Pharmacol Exp Ther | Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice. | 2011 | Details |
| A25386 | 21901160 | PLoS One | Maternal obesity during gestation impairs fatty acid oxidation and mitochondrial SIRT3 expression in rat offspring at weaning. | 2011 | Details |
| A25387 | 21898634 | Ultrasound Obstet Gynecol | Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome. | 2012 | Details |
| A25390 | 21898479 | Hepatology | Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. | 2011 | Details |
| A25392 | 21894514 | Endocrine | Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments. | 2011 | Details |
| A25393 | 21894292 | Med Ultrason | Association between fatty liver disease and carotid atherosclerosis in patients with uncomplicated type 2 diabetes mellitus. | 2011 | Details |
| A25395 | 21894008 | Dig Dis | Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis. | 2011 | Details |
| A25397 | 21893273 | Gastroenterol Clin North Am | Nonalcoholic fatty liver disease: pharmacologic and surgical options. | 2011 | Details |
| A25403 | 21886908 | Sci Pharm | Type 2 Diabetes Mellitus-Induced Hyperglycemia in Patients with NAFLD and Normal LFTs: Relationship to Lipid Profile, Oxidative Stress and Pro-Inflammatory Cytokines. | 2011 | Details |
| A25417 | 21876630 | World J Gastroenterol | Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. | 2011 | Details |
| A25418 | 21876629 | World J Gastroenterol | Nutritional recommendations for patients with non-alcoholic fatty liver diseases. | 2011 | Details |
| A25420 | 21875310 | Crit Rev Clin Lab Sci | Non-alcoholic fatty liver disease. | 2011 | Details |
| A25422 | 21873555 | FASEB J | Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet. | 2011 | Details |
| A25430 | 21855538 | Exp Mol Pathol | Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation. | 2011 | Details |
| A25433 | 21852905 | Korean J Radiol | Evaluation of portal venous velocity with Doppler ultrasound in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25438 | 21841322 | Intern Med | Serum dehydroepiandrosterone sulphate levels in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25439 | 21840395 | Biochim Biophys Acta | Genetic modifiers of non-alcoholic fatty liver disease progression. | 2011 | Details |
| A25443 | 21836057 | Am J Physiol Gastrointest Liver Physiol | Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. | 2011 | Details |
| A25449 | 21821020 | Exp Mol Pathol | Liver mitochondrial function and redox status in an experimental model of non-alcoholic fatty liver disease induced by monosodium L-glutamate in rats. | 2011 | Details |
| A25450 | 21818154 | Obesity (Silver Spring) | Perinephric and epididymal fat affect hepatic metabolism in rats. | 2011 | Details |
| A25461 | 21807931 | JPEN J Parenter Enteral Nutr | Monitoring nutrition therapy in the critically ill patient with obesity. | 2011 | Details |
| A25464 | 21805421 | Turk J Gastroenterol | The prevalence of celiac disease among patients with non-alcoholic fatty liver disease in Iran. | 2011 | Details |
| A25466 | 21801491 | Redox Rep | Unbalanced oxidant-antioxidant status and its effects in pediatric diseases. | 2011 | Details |
| A25468 | 21799647 | World J Gastroenterol | T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease. | 2011 | Details |
| A25469 | 21799478 | Obesity (Silver Spring) | Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. | 2011 | Details |
| A25471 | 21796479 | Endocrine | Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males. | 2011 | Details |
| A25480 | 21787451 | Br J Nutr | Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice. | 2011 | Details |
| A25481 | 21787405 | Lipids Health Dis | Effect of α-linolenic acid on endoplasmic reticulum stress-mediated apoptosis of palmitic acid lipotoxicity in primary rat hepatocytes. | 2011 | Details |
| A25482 | 21781943 | J Hepatol | High fructose feeding induces copper deficiency in Sprague-Dawley rats: a novel mechanism for obesity related fatty liver. | 2011 | Details |
| A25483 | 21779332 | PLoS One | Offspring of mothers fed a high fat diet display hepatic cell cycle inhibition and associated changes in gene expression and DNA methylation. | 2011 | Details |
| A25489 | 21773052 | J Lipids | Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation. | 2011 | Details |
| A25491 | 21770819 | Scand J Gastroenterol | Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis. | 2011 | Details |
| A25499 | 21765869 | Therap Adv Gastroenterol | The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis. | 2011 | Details |
| A25501 | 21764273 | Nutr Metab Cardiovasc Dis | Obesity and metabolic syndrome: potential benefit from specific nutritional components. | 2011 | Details |
| A25502 | 21764223 | Med Hypotheses | Full-spectrum antioxidant therapy featuring astaxanthin coupled with lipoprivic strategies and salsalate for management of non-alcoholic fatty liver disease. | 2011 | Details |
| A25505 | 21760546 | J Pediatr Gastroenterol Nutr | Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children. | 2012 | Details |
| A25511 | 21751850 | Platelets | The association between non-alcoholic hepatic steatosis and mean platelet volume in an obese Korean population. | 2011 | Details |
| A25512 | 21751587 | J Assoc Physicians India | Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. | 2011 | Details |
| A25519 | 21748768 | Hepatology | Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis. | 2011 | Details |
| A25521 | 21748549 | J Gastroenterol | Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey. | 2011 | Details |
| A25529 | 21744131 | Obes Surg | Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25532 | 21740524 | FEBS J | Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice. | 2011 | Details |
| A25533 | 21740407 | Br J Pharmacol | Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis. | 2012 | Details |
| A25534 | 21738618 | PLoS One | Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence. | 2011 | Details |
| A25536 | 21737754 | J Lipid Res | Quantification of liver fat in mice: comparing dual-echo Dixon imaging, chemical shift imaging, and 1H-MR spectroscopy. | 2011 | Details |
| A25539 | 21734787 | World J Gastroenterol | Adiponectin, a key adipokine in obesity related liver diseases. | 2011 | Details |
| A25540 | 21734391 | Dig Dis | Pathophysiology of non-alcoholic steatohepatitis and basis for treatment. | 2011 | Details |
| A25541 | 21734385 | Dig Dis | ASH and NASH. | 2011 | Details |
| A25543 | 21733326 | Br J Nutr | Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress. | 2011 | Details |
| A25545 | 21727734 | Saudi J Gastroenterol | Genetic polymorphisms in non-alcoholic fatty liver disease in obese Egyptian children. | 2011 | Details |
| A25552 | 21723084 | Presse Med | [Nonalcoholic fatty liver disease]. | 2011 | Details |
| A25557 | 21713513 | Appl Microbiol Biotechnol | Large-scale expression, purification, and glucose uptake activity of recombinant human FGF21 in Escherichia coli. | 2011 | Details |
| A25559 | 21711426 | Hepatol Res | NASH: A global health problem. | 2011 | Details |
| A25562 | 21709958 | Arq Gastroenterol | Hepatic and biochemical repercussions of a polyunsaturated fat-rich hypercaloric and hyperlipidic diet in Wistar rats. | 2012 | Details |
| A25573 | 21703181 | J Hepatol | Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. | 2011 | Details |
| A25577 | 21700865 | Science | Human fatty liver disease: old questions and new insights. | 2011 | Details |
| A25578 | 21697744 | J Pediatr Gastroenterol Nutr | Biochemical parameters and anthropometry predict NAFLD in obese children. | 2011 | Details |
| A25582 | 21690266 | J Lipid Res | Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. | 2011 | Details |
| A25585 | 21688564 | Rev Med Chir Soc Med Nat Iasi | [The influence and prevalence of nonalcoholic steatohepatitis in chronic hepatitis B]. | 2011 | Details |
| A25587 | 21684478 | Arab J Gastroenterol | Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin. | 2011 | Details |
| A25591 | 21678341 | Cochrane Database Syst Rev | Weight reduction for non-alcoholic fatty liver disease. | 2011 | Details |
| A25594 | 21674556 | Hepatology | Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis. | 2011 | Details |